Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Obesity Drug choice in pregnancy Effects of antipsychotic medications on plasma lipids Treatment of antipsychotic-induced weight gain Diabetes and impaired glucose tolerance ECG changes - QT prolongation Psychosis in children and adolescents
Obsessive compulsive disorder Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents with autism spectrum disorder
obsessive compulsive disorder (OCD)
Ocular effects, antipsychotics
Oestrogen antipsychotic effects selective oestrogen receptor modulators decline in menopausal women
Oestrogen interactions
Olanzapine/samidorphan combination, bipolar disorder
Olanzapine pamoate Quick reference for licensed maximum doses Equivalent doses
Older people alzheimerâ™s disease covert administration of medicines in food and drink drugs inappropriate sexual behaviour behavioural and psychological symptoms of dementia management dose recommendations for common psychotropics general prescribing principles
Omega-3 (polyunsaturated) fatty acids (fish oils or supplements) dyslipidaemia treatment schizophrenia treatment and prevention borderline personality disorder mild/moderate depression in older adults tardive dyskinesia
Ondansetron Alternatives to clozapine Treatment of tardive dyskinesia
Onset of action
Opioid dependence changes in prescribing practice opioid receptor agonists, buprenorphine versus methadone or opioids prescribing psychotropic medications Opioid dependence overdose timecourse of withdrawal symptoms
Opioids detoxification and reduction regimens diversion potential of misused substances misuse overdose symptoms and treatment relapse prevention with naltrexone safety in older patients/dementia driving impairment overdose risk after detoxification psychiatric adverse effects safe storage importance transferring from prescription drugs to buprenorphine
Object relations
obstetric and gynaecological haemorrhage, SSRI risks
Oesophageal varices, consequences of reduced hepatic blood flow
Oestrogen augmentation
Olanzapine/fluoxetine combination, children and adolescents with bipolar depression
Olanzapine
Opioid antagonists, borderline personality disorder
opioid substitution treatment (OST) 500-519 alternative oral preparations pain control in patients relapse prevention with naltrexone slow-release oral morphine induction and stabilisation of maintenance treatment paliperidone diamorphine safe prescribing
Opioid withdrawal community settings specialist addiction in-patient settings treatment of symptoms buprenorphine methadone timecourse of symptoms validated scales
Optimal dosage
Options for menopausal women
Orlistat for antipsychotic-induced weight gain for constipation treatment
orodispersible drug administration, Espranor/buprenorphine
Orthostatic hypotension Switching antipsychotics Blood pressure changes with antipsychotics
Other options for the treatment of tardive dyskinesia (in αbetical order)
Other psychotropic drugs in renal impairment